Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy

References

• MacDonagh L, Gray SG, Breen E, et al. Lung cancer stem cells: the root of resistance. Cancer Lett. 2016;372(2):147–156. doi:10.1016/j.canlet.2016.01.01226797015
   PubMed Web of Science ®Google Scholar
• Rosell R, Karachaliou N. Lung cancer in 2014: optimizing lung cancer treatment approaches. Nat Rev Clin Oncol. 2015;12(2):75–76. doi:10.1038/nrclinonc.2014.22525533943
   PubMed Web of Science ®Google Scholar
• Yuwen D, Ma Y, Wang D, et al. Prognostic role of circulating exosomal miR-425-3p for the response of NSCLC to platinum-based chemotherapy. Cancer Epidemiol Biomarkers Prev. 2019;28(1):163–173. doi:10.1158/1055-9965.EPI-18-056930228154
   PubMed Web of Science ®Google Scholar
• Wang X, Chen X, Meng Q, et al. MiR-181b regulates cisplatin chemosensitivity and metastasis by targeting TGFbetaR1/Smad signaling pathway in NSCLC. Sci Rep. 2015;5:17618. doi:10.1038/srep1761826620926
   PubMedGoogle Scholar
• Zhao J, Fu W, Liao H, et al. The regulatory and predictive functions of miR-17 and miR-92 families on cisplatin resistance of non-small cell lung cancer. BMC Cancer. 2015;15:731. doi:10.1186/s12885-015-1584-326482648
   PubMed Web of Science ®Google Scholar
• Zang H, Wang W, Fan S. The role of microRNAs in resistance to targeted treatments of non-small cell lung cancer. Cancer Chemother Pharmacol. 2017;79(2):227–231. doi:10.1007/s00280-016-3130-727515517
   PubMedGoogle Scholar
• Zang H, Peng J, Wang W, Fan S. Roles of microRNAs in the resistance to platinum based chemotherapy in the non-small cell lung cancer. J Cancer. 2017;8(18):3856–3861. doi:10.7150/jca.2126729151973
   PubMed Web of Science ®Google Scholar
• Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002;2(8):569–579. doi:10.1038/nri85512154376
   PubMed Web of Science ®Google Scholar
• Martins VR, Dias MS, Hainaut P. Tumor-cell-derived microvesicles as carriers of molecular information in cancer. Curr Opin Oncol. 2013;25(1):66–75. doi:10.1097/CCO.0b013e32835b7c8123165142
   PubMed Web of Science ®Google Scholar
• Skog J, Wurdinger T, van Rijn S, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008;10(12):1470–1476. doi:10.1038/ncb180019011622
   PubMed Web of Science ®Google Scholar
• Kong JN, He Q, Wang G, et al. Guggulsterone and bexarotene induce secretion of exosome-associated breast cancer resistance protein and reduce doxorubicin resistance in MDA-MB-231 cells. Int J Cancer. 2015;137(7):1610–1620. doi:10.1002/ijc.2954225833198
   PubMedGoogle Scholar
• Qin X, Yu S, Zhou L, et al. Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017;12:3721–3733. doi:10.2147/IJN.S13151628553110
   PubMed Web of Science ®Google Scholar
• Huang X, Yuan T, Liang M, et al. Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer. Eur Urol. 2015;67(1):33–41. doi:10.1016/j.eururo.2014.07.03525129854
   PubMed Web of Science ®Google Scholar
• Li L, Li C, Wang S, et al. Exosomes derived from hypoxic oral squamous cell carcinoma cells deliver miR-21 to normoxic cells to elicit a prometastatic phenotype. Cancer Res. 2016;76(7):1770–1780. doi:10.1158/0008-5472.CAN-15-162526992424
   PubMed Web of Science ®Google Scholar
• Wang M, Zhao C, Shi H, et al. Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer. Br J Cancer. 2014;110(5):1199–1210. doi:10.1038/bjc.2014.1424473397
   PubMedGoogle Scholar
• Mi S, Xiang G, Yuwen D, et al. Inhibition of autophagy by andrographolide resensitizes cisplatin-resistant non-small cell lung carcinoma cells via activation of the Akt/mTOR pathway. Toxicol Appl Pharmacol. 2016;310:78–86. doi:10.1016/j.taap.2016.09.00927639426
   PubMedGoogle Scholar
• Li X, Pang J, Xue W, et al. Inducible SHP-2 activation confers resistance to imatinib in drug-tolerant chronic myeloid leukemia cells. Toxicol Appl Pharmacol. 2018;360:249–256. doi:10.1016/j.taap.2018.09.04430290167
   PubMedGoogle Scholar
• Dasari S, Tchounwou PB. Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol. 2014;740:364–378. doi:10.1016/j.ejphar.2014.07.02525058905
   PubMed Web of Science ®Google Scholar
• Xie C, Pan Y, Hao F, et al. C-Myc participates in beta-catenin-mediated drug resistance in A549/DDP lung adenocarcinoma cells. APMIS. 2014;122(12):1251–1258. doi:10.1111/apm.1229625131138
   PubMedGoogle Scholar
• Vesel M, Rapp J, Feller D, et al. ABCB1 and ABCG2 drug transporters are differentially expressed in non-small cell lung cancers (NSCLC) and expression is modified by cisplatin treatment via altered Wnt signaling. Respir Res. 2017;18(1):52. doi:10.1186/s12931-017-0537-628340578
   PubMedGoogle Scholar
• Zhou J, Hu SE, Tan SH, et al. Andrographolide sensitizes cisplatin-induced apoptosis via suppression of autophagosome-lysosome fusion in human cancer cells. Autophagy. 2012;8(3):338–349. doi:10.4161/auto.1872122302005
   PubMed Web of Science ®Google Scholar
• White E. Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer. 2012;12(6):401–410. doi:10.1038/nrc326222534666
   PubMed Web of Science ®Google Scholar
• Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA. MicroRNAs in body fluids–the mix of hormones and biomarkers. Nat Rev Clin Oncol. 2011;8(8):467–477. doi:10.1038/nrclinonc.2011.7621647195
   PubMed Web of Science ®Google Scholar
• Schwarzenbach H. The clinical relevance of circulating, exosomal miRNAs as biomarkers for cancer. Expert Rev Mol Diagn. 2015;15(9):1159–1169. doi:10.1586/14737159.2015.106918326202667
   PubMed Web of Science ®Google Scholar
• Melo SA, Sugimoto H, O’Connell JT, et al. Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer Cell. 2014;26(5):707–721. doi:10.1016/j.ccell.2014.09.00525446899
   PubMed Web of Science ®Google Scholar
• Wu J, Zhang H, Wang W, et al. Plasma microRNA signature of patients with IgA nephropathy. Gene. 2018;649:80–86. doi:10.1016/j.gene.2018.01.05029459010
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhao H, Gao X, et al. Identification of a three-miRNA signature as a blood-borne diagnostic marker for early diagnosis of lung adenocarcinoma. Oncotarget. 2016;7(18):26070–26086. doi:10.18632/oncotarget.842927036025
   PubMedGoogle Scholar
• Vaira V, Roncalli M, Carnaghi C, et al. MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma. Liver Int. 2015;35(3):1077–1086. doi:10.1111/liv.1263625040368
   PubMedGoogle Scholar
• Liao J, Liu R, Yin L, Pu Y. Expression profiling of exosomal miRNAs derived from human esophageal cancer cells by Solexa high-throughput sequencing. Int J Mol Sci. 2014;15(9):15530–15551. doi:10.3390/ijms15091553025184951
   PubMed Web of Science ®Google Scholar
• Dong C, Liu X, Wang H, et al. Hypoxic non-small-cell lung cancer cell-derived exosomal miR-21 promotes resistance of normoxic cell to cisplatin. Onco Targets Ther. 2019;12:1947–1956. doi:10.2147/OTT.S18692230881046
   PubMed Web of Science ®Google Scholar
• Xiao X, Yu S, Li S, et al. Exosomes: decreased sensitivity of lung cancer A549 cells to cisplatin. PLoS One. 2014;9(2):e89534. doi:10.1371/journal.pone.008953424586853
   PubMed Web of Science ®Google Scholar
• Jia X, Zhang Z, Luo K, et al. TCRP1 transcriptionally regulated by c-Myc confers cancer chemoresistance in tongue and lung cancer. Sci Rep. 2017;7(1):3744. doi:10.1038/s41598-017-03763-028623290
   PubMedGoogle Scholar
• Chen D, Huang J, Zhang K, et al. MicroRNA-451 induces epithelial-mesenchymal transition in docetaxel-resistant lung adenocarcinoma cells by targeting proto-oncogene c-Myc. Eur J Cancer. 2014;50(17):3050–3067. doi:10.1016/j.ejca.2014.09.00825310895
   PubMed Web of Science ®Google Scholar
• Fu Q, Song X, Liu Z, et al. miRomics and proteomics reveal a miR-296-3p/PRKCA/FAK/Ras/c-Myc lated by HDGF/DDX5/beta-catenin complex in lung adenocarcinoma. Clin Cancer Res. 2017;23(20):6336–6350. doi:10.1158/1078-0432.CCR-16-281328751441
   PubMed Web of Science ®Google Scholar
• Marino G, Niso-Santano M, Baehrecke EH, Kroemer G. Self-consumption: the interplay of autophagy and apoptosis. Nat Rev Mol Cell Biol. 2014;15(2):81–94. doi:10.1038/nrm373524401948
   PubMed Web of Science ®Google Scholar
• Yuwen D, Mi S, Ma Y, et al. Andrographolide enhances cisplatin-mediated anticancer effects in lung cancer cells through blockade of autophagy. Anticancer Drugs. 2017;28(9):967–976. doi:10.1097/CAD.000000000000053728692436
   PubMed Web of Science ®Google Scholar